Compare DIN & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DIN | ANGO |
|---|---|---|
| Founded | 1958 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 326.8M | 420.2M |
| IPO Year | 1994 | 2004 |
| Metric | DIN | ANGO |
|---|---|---|
| Price | $27.97 | $10.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | ★ $29.00 | $18.00 |
| AVG Volume (30 Days) | 324.8K | ★ 513.0K |
| Earning Date | 05-06-2026 | 04-02-2026 |
| Dividend Yield | ★ 2.75% | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | ★ 1.11 | N/A |
| Revenue | ★ $879,300,000.00 | $291,010,000.00 |
| Revenue This Year | $3.61 | $9.51 |
| Revenue Next Year | $0.64 | $4.96 |
| P/E Ratio | $24.94 | ★ N/A |
| Revenue Growth | 8.25 | ★ 10.17 |
| 52 Week Low | $19.00 | $8.36 |
| 52 Week High | $39.68 | $13.99 |
| Indicator | DIN | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 51.71 | 48.99 |
| Support Level | $27.52 | $10.38 |
| Resistance Level | $28.90 | $11.06 |
| Average True Range (ATR) | 1.32 | 0.57 |
| MACD | 0.35 | -0.00 |
| Stochastic Oscillator | 90.62 | 42.88 |
Dine Brands Global Inc owns and franchises thousands of restaurants under the International House of Pancakes (IHOP), Applebee's Neighborhood Grill + Bar (Applebee's), and the Fuzzy's Taco Shop (Fuzzy's) names. The company conducts its business through three reportable segments: Franchise, Company-owned restaurants, and Rental. The majority of its revenue is generated from the Franchise segment, which consists of IHOP, Applebee's, and Fuzzy's franchise operations and generates revenue mainly from royalties and advertising fees from several IHOP, Applebee's, and Fuzzy's franchised restaurants, in addition to revenues from the sale of proprietary IHOP and Fuzzy's products to its franchisees. Geographically, the majority of the company's revenues is generated from its domestic market.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.